At the Drug Safety Research Unit (DSRU), our aim is to achieve the highest possible scientific and ethical standards, by putting the interests of patients first and to work with integrity and fairness with all our partners.

Through our historical links with doctors in the NHS, the unit conducts studies in both primary and secondary care, many of which are risk management studies which are part of Risk Management Plans (RMPs) in the EU.

Our activities are principally concerned with pharmacovigilance, that is, the detection of side-effects associated with the use of marketed drugs. The DSRU undertakes all forms of research studies and evaluations of the safety of medicines.

We are an independent unit providing scientific excellence demonstrated through conducting studies, which have been used to support public health decisions and production of publications in international peer reviewed journals since 1980.

The DSRU makes significant, valuable contributions in the area of post marketing surveillance of pharmaceutical products. We have achieved both recognition and endorsement by regulatory authorities, healthcare professionals and the pharmaceutical industry worldwide.

Health Care

Life Sciences

Pharmaceutical

Research

Drug Safety Research Unit (DSRU)

Drug Safety Research Unit (DSRU)'s headquarters in Southampton, United Kingdom

Saad Shakir

Fiona S.

Liz Lynn

Samantha Lane

Debabrata Roy

Research and Education

Drug Safety Research Unit (DSRU)

Org chart

Teams

Research and Education

Offices

Similar companies